Literature DB >> 9637922

Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44.

J W Legg1, C M Isacke.   

Abstract

ERM (ezrin, radixin and moesin) proteins function as linkers between the actin cytoskeleton and the plasma membrane. In addition to this structural role, these proteins are highly regulatable making them ideal candidates to mediate important physiological events such as adhesion and membrane morphology and to control formation and breakdown of membrane-cytoskeletal junctions. Recently, a direct interaction in vitro has been demonstrated between ERM proteins and the hyaluronan receptor, CD44. We have mapped the ezrin-binding site to two clusters of basic amino acids in a membrane-proximal 9 amino-acid region within the CD44 cytoplasmic domain. To investigate the functional importance of this interaction in vivo, we created a number of mutations within full-length CD44 and expressed these mutants in human melanoma cells. We demonstrate here that mutations within the ezrin-binding site do not disrupt the plasma membrane localization of CD44 and, in addition, that this region is not required to mediate efficient hyaluronan binding. These studies suggest that ERM proteins mediate the outside-in, rather than inside-out, signalling of adhesion receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637922     DOI: 10.1016/s0960-9822(98)70277-5

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  56 in total

1.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tail of adhesion molecule CD44.

Authors:  Tomoyuki Mori; Ken Kitano; Shin-ichi Terawaki; Ryoko Maesaki; Toshio Hakoshima
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-09-19

3.  RKIKK motif in the intracellular domain is critical for spatial and dynamic organization of ICAM-1: functional implication for the leukocyte adhesion and transmigration.

Authors:  Hyun-Mee Oh; SungGa Lee; Bo-Ra Na; Hyun Wee; Sang-Hyun Kim; Suck-Chei Choi; Kang-Min Lee; Chang-Duk Jun
Journal:  Mol Biol Cell       Date:  2007-04-11       Impact factor: 4.138

4.  The organelle proteome of the DT40 lymphocyte cell line.

Authors:  Stephanie L Hall; Svenja Hester; Julian L Griffin; Kathryn S Lilley; Antony P Jackson
Journal:  Mol Cell Proteomics       Date:  2009-01-30       Impact factor: 5.911

5.  Intracellular domain fragment of CD44 alters CD44 function in chondrocytes.

Authors:  Liliana Mellor; Cheryl B Knudson; Daisuke Hida; Emily B Askew; Warren Knudson
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

6.  Human neutrophil surface protrusion under a point load: location independence and viscoelasticity.

Authors:  Gang Xu; Jin-Yu Shao
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-24       Impact factor: 4.249

7.  E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling.

Authors:  Tadayuki Yago; Bojing Shao; Jonathan J Miner; Longbiao Yao; Arkadiusz G Klopocki; Kenichiro Maeda; K Mark Coggeshall; Rodger P McEver
Journal:  Blood       Date:  2010-03-18       Impact factor: 22.113

8.  Age-related defects in moesin/ezrin cytoskeletal signals in mouse CD4 T cells.

Authors:  Gonzalo G Garcia; Amir A Sadighi Akha; Richard A Miller
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

9.  A role for the juxtamembrane domain of beta-dystroglycan in agrin-induced acetylcholine receptor clustering.

Authors:  Joanna Kahl; James T Campanelli
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

Review 10.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.